nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ABCB1—adrenal gland cancer	0.957	1	CbGaD
Trazodone—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00114	0.178	CbGeAlD
Trazodone—HTR2A—vein—adrenal gland cancer	0.00107	0.166	CbGeAlD
Trazodone—Domperidone—ABCB1—adrenal gland cancer	0.000877	0.216	CrCbGaD
Trazodone—Nefazodone—ABCB1—adrenal gland cancer	0.000728	0.18	CrCbGaD
Trazodone—Aripiprazole—ABCB1—adrenal gland cancer	0.000677	0.167	CrCbGaD
Trazodone—HTR2A—urine—adrenal gland cancer	0.000627	0.0974	CbGeAlD
Trazodone—CYP3A4—urine—adrenal gland cancer	0.000581	0.0901	CbGeAlD
Trazodone—CYP2D6—urine—adrenal gland cancer	0.000571	0.0887	CbGeAlD
Trazodone—Fluphenazine—ABCB1—adrenal gland cancer	0.000546	0.135	CrCbGaD
Trazodone—Trifluoperazine—ABCB1—adrenal gland cancer	0.000436	0.108	CrCbGaD
Trazodone—Quetiapine—ABCB1—adrenal gland cancer	0.000423	0.104	CrCbGaD
Trazodone—Clozapine—ABCB1—adrenal gland cancer	0.000364	0.0899	CrCbGaD
Trazodone—HTR2B—adrenal cortex—adrenal gland cancer	0.000311	0.0483	CbGeAlD
Trazodone—HTR2B—adrenal gland—adrenal gland cancer	0.000225	0.0349	CbGeAlD
Trazodone—HTR1A—adrenal gland—adrenal gland cancer	0.000201	0.0312	CbGeAlD
Trazodone—ADRA1A—adrenal gland—adrenal gland cancer	0.000186	0.0288	CbGeAlD
Trazodone—ADRA2A—gonad—adrenal gland cancer	0.000162	0.0251	CbGeAlD
Trazodone—ADRA2A—cardiac atrium—adrenal gland cancer	0.000162	0.0251	CbGeAlD
Trazodone—ADRA2A—pituitary gland—adrenal gland cancer	0.000158	0.0245	CbGeAlD
Trazodone—HRH1—adrenal gland—adrenal gland cancer	0.000144	0.0223	CbGeAlD
Trazodone—ADRA2A—adrenal gland—adrenal gland cancer	0.000141	0.0219	CbGeAlD
Trazodone—HTR2A—gonad—adrenal gland cancer	0.000138	0.0214	CbGeAlD
Trazodone—HTR2A—pituitary gland—adrenal gland cancer	0.000134	0.0208	CbGeAlD
Trazodone—HTR2A—adrenal gland—adrenal gland cancer	0.00012	0.0186	CbGeAlD
Trazodone—ABCB1—adrenal cortex—adrenal gland cancer	0.000109	0.0169	CbGeAlD
Trazodone—ABCB1—gonad—adrenal gland cancer	9.02e-05	0.014	CbGeAlD
Trazodone—ABCB1—pituitary gland—adrenal gland cancer	8.8e-05	0.0137	CbGeAlD
Trazodone—ABCB1—adrenal gland—adrenal gland cancer	7.86e-05	0.0122	CbGeAlD
Trazodone—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	4.7e-05	0.00143	CbGpPWpGaD
Trazodone—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	4.69e-05	0.00143	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	4.69e-05	0.00143	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—TSHR—adrenal gland cancer	4.68e-05	0.00142	CbGpPWpGaD
Trazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	4.6e-05	0.0014	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	4.59e-05	0.0014	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	4.54e-05	0.00138	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	4.53e-05	0.00138	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ZNRF3—adrenal gland cancer	4.53e-05	0.00138	CbGpPWpGaD
Trazodone—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	4.5e-05	0.00137	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CDC42—adrenal gland cancer	4.49e-05	0.00137	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	4.44e-05	0.00135	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—GNRH1—adrenal gland cancer	4.44e-05	0.00135	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	4.39e-05	0.00134	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	4.36e-05	0.00133	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	4.32e-05	0.00132	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—GNAS—adrenal gland cancer	4.29e-05	0.00131	CbGpPWpGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	4.28e-05	0.0013	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—SDHB—adrenal gland cancer	4.27e-05	0.0013	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	4.27e-05	0.0013	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	4.14e-05	0.00126	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	4.13e-05	0.00126	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	4.13e-05	0.00126	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—POMC—adrenal gland cancer	4.12e-05	0.00125	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CDC42—adrenal gland cancer	4.08e-05	0.00124	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SPRY2—adrenal gland cancer	4.06e-05	0.00124	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SDHB—adrenal gland cancer	4.02e-05	0.00122	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—RRM1—adrenal gland cancer	3.98e-05	0.00121	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—SDHD—adrenal gland cancer	3.98e-05	0.00121	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TSHR—adrenal gland cancer	3.95e-05	0.0012	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	3.9e-05	0.00119	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—GNAS—adrenal gland cancer	3.89e-05	0.00119	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—PRKACA—adrenal gland cancer	3.88e-05	0.00118	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—MED12—adrenal gland cancer	3.76e-05	0.00114	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MEN1—adrenal gland cancer	3.72e-05	0.00113	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—SDHD—adrenal gland cancer	3.65e-05	0.00111	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—RRM1—adrenal gland cancer	3.65e-05	0.00111	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	3.64e-05	0.00111	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CDC42—adrenal gland cancer	3.62e-05	0.0011	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	3.6e-05	0.0011	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	3.59e-05	0.00109	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	3.58e-05	0.00109	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—GNRH1—adrenal gland cancer	3.58e-05	0.00109	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	3.58e-05	0.00109	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—POMC—adrenal gland cancer	3.57e-05	0.00109	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	3.51e-05	0.00107	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	3.5e-05	0.00107	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	3.5e-05	0.00107	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	3.48e-05	0.00106	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	3.46e-05	0.00105	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	3.37e-05	0.00102	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	3.36e-05	0.00102	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	3.3e-05	0.00101	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	3.3e-05	0.001	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	3.29e-05	0.001	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	3.29e-05	0.001	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	3.27e-05	0.000997	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	3.26e-05	0.000991	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	3.21e-05	0.000976	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.19e-05	0.000972	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	3.19e-05	0.000971	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	3.16e-05	0.000961	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	3.14e-05	0.000957	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	3.14e-05	0.000956	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	3.14e-05	0.000955	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	3.13e-05	0.000954	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	3.11e-05	0.000946	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	3.1e-05	0.000944	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	3.08e-05	0.000937	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	3.06e-05	0.000932	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	3.04e-05	0.000926	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	3.02e-05	0.000918	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	3e-05	0.000914	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	3e-05	0.000913	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	3e-05	0.000912	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—MED12—adrenal gland cancer	2.97e-05	0.000903	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	2.94e-05	0.000895	CbGpPWpGaD
Trazodone—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.94e-05	0.000895	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—POMC—adrenal gland cancer	2.89e-05	0.000879	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	2.86e-05	0.000871	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	2.86e-05	0.000869	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	2.85e-05	0.000867	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	2.84e-05	0.000865	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PRKACA—adrenal gland cancer	2.84e-05	0.000864	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	2.84e-05	0.000864	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	2.83e-05	0.000861	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	2.8e-05	0.000851	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	2.78e-05	0.000847	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	2.77e-05	0.000843	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	2.76e-05	0.000842	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—RRM1—adrenal gland cancer	2.75e-05	0.000837	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—SDHD—adrenal gland cancer	2.75e-05	0.000837	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	2.74e-05	0.000835	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	2.73e-05	0.000832	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	2.73e-05	0.00083	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	2.72e-05	0.000829	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—MED12—adrenal gland cancer	2.72e-05	0.000827	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	2.71e-05	0.000826	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	2.67e-05	0.000813	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.63e-05	0.0008	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	2.62e-05	0.000798	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	2.6e-05	0.000793	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	2.6e-05	0.000791	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	2.6e-05	0.000791	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—RRM1—adrenal gland cancer	2.59e-05	0.000789	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SDHD—adrenal gland cancer	2.59e-05	0.000789	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.59e-05	0.000788	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	2.59e-05	0.000787	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	2.55e-05	0.000776	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	2.52e-05	0.000767	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.48e-05	0.000756	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	2.48e-05	0.000755	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	2.41e-05	0.000733	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	2.37e-05	0.000721	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	2.34e-05	0.000713	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	2.33e-05	0.000709	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	2.32e-05	0.000706	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	2.3e-05	0.000701	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	2.3e-05	0.0007	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	2.29e-05	0.000697	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	2.24e-05	0.000683	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GNAS—adrenal gland cancer	2.22e-05	0.000677	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	2.18e-05	0.000664	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	2.16e-05	0.000659	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	2.13e-05	0.000647	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	2.12e-05	0.000644	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.08e-05	0.000634	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—MED12—adrenal gland cancer	2.05e-05	0.000624	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	2.02e-05	0.000616	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	2.02e-05	0.000614	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	1.99e-05	0.000605	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	1.98e-05	0.000604	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	1.98e-05	0.000603	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	1.98e-05	0.000603	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	1.95e-05	0.000594	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	1.95e-05	0.000593	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	1.94e-05	0.000591	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—MED12—adrenal gland cancer	1.93e-05	0.000588	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	1.93e-05	0.000588	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	1.88e-05	0.000573	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	1.87e-05	0.00057	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	1.87e-05	0.000568	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	1.86e-05	0.000565	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	1.84e-05	0.00056	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	1.84e-05	0.000559	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	1.83e-05	0.000558	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	1.82e-05	0.000554	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	1.81e-05	0.000551	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	1.81e-05	0.000551	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	1.8e-05	0.000547	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GNAS—adrenal gland cancer	1.75e-05	0.000534	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	1.72e-05	0.000524	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.69e-05	0.000516	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.69e-05	0.000516	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	1.69e-05	0.000513	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	1.68e-05	0.000512	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	1.68e-05	0.000511	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	1.67e-05	0.000509	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	1.65e-05	0.000503	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	1.63e-05	0.000495	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	1.62e-05	0.000494	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	1.61e-05	0.000491	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	1.61e-05	0.000489	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GNAS—adrenal gland cancer	1.61e-05	0.000489	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	1.59e-05	0.000485	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	1.58e-05	0.00048	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	1.58e-05	0.00048	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	1.57e-05	0.000478	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	1.57e-05	0.000477	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	1.57e-05	0.000477	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	1.56e-05	0.000474	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	1.55e-05	0.000471	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	1.54e-05	0.000468	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	1.53e-05	0.000467	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	1.53e-05	0.000466	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—POMC—adrenal gland cancer	1.5e-05	0.000456	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.5e-05	0.000455	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	1.48e-05	0.000451	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	1.48e-05	0.00045	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	1.47e-05	0.000446	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	1.43e-05	0.000435	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	1.41e-05	0.000429	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TP53—adrenal gland cancer	1.38e-05	0.000421	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	1.36e-05	0.000415	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	1.36e-05	0.000413	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	1.35e-05	0.000412	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TERT—adrenal gland cancer	1.35e-05	0.000411	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	1.32e-05	0.000403	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.26e-05	0.000385	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	1.26e-05	0.000382	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	1.25e-05	0.00038	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	1.24e-05	0.000378	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	1.23e-05	0.000376	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	1.23e-05	0.000375	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.21e-05	0.000369	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	1.2e-05	0.000366	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	1.2e-05	0.000364	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	1.19e-05	0.000363	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—POMC—adrenal gland cancer	1.18e-05	0.000359	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	1.18e-05	0.000358	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—BAD—adrenal gland cancer	1.17e-05	0.000358	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	1.15e-05	0.000351	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.14e-05	0.000348	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.12e-05	0.000341	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.11e-05	0.000336	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	1.09e-05	0.00033	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—POMC—adrenal gland cancer	1.08e-05	0.00033	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—POMC—adrenal gland cancer	1.08e-05	0.000329	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	1.07e-05	0.000326	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	1.07e-05	0.000326	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	1.07e-05	0.000325	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	1.06e-05	0.000323	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	1.05e-05	0.000319	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.04e-05	0.000316	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	1.04e-05	0.000315	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	1.02e-05	0.00031	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	9.87e-06	0.0003	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	9.75e-06	0.000297	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	9.45e-06	0.000288	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	9.42e-06	0.000287	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	9.22e-06	0.000281	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	8.96e-06	0.000273	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	8.92e-06	0.000271	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	8.76e-06	0.000267	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	8.63e-06	0.000263	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—POMC—adrenal gland cancer	8.16e-06	0.000249	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.74e-06	0.000236	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	7.73e-06	0.000235	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—POMC—adrenal gland cancer	7.69e-06	0.000234	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.58e-06	0.000231	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	7.47e-06	0.000227	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	7.35e-06	0.000224	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	7.33e-06	0.000223	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	7.1e-06	0.000216	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	7.07e-06	0.000215	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.05e-06	0.000214	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—adrenal gland cancer	6.51e-06	0.000198	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	6.14e-06	0.000187	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	6.14e-06	0.000187	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	6.12e-06	0.000186	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	6.01e-06	0.000183	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	5.96e-06	0.000182	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	5.93e-06	0.000181	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	5.58e-06	0.00017	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	5.15e-06	0.000157	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—adrenal gland cancer	5.14e-06	0.000156	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	5.04e-06	0.000154	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—POMC—adrenal gland cancer	5.03e-06	0.000153	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	4.69e-06	0.000143	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4.01e-06	0.000122	CbGpPWpGaD
